List of Contents

Point of Care Testing Market Size, Share, and Trends 2024 to 2034

The global point of care testing market size accounted for USD 39.64 billion in 2024, grew to USD 44.48 billion in 2025 and is predicted to surpass around USD 125.33 billion by 2034, representing a healthy CAGR of 12.20% between 2024 and 2034. The North America point of care testing market size is calculated at USD 18.23 billion in 2024 and is expected to grow at a fastest CAGR of 12.31% during the forecast year.

  • Last Updated : November 2024
  • Report Code : 2270
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Point-of-Care Testing (POCT) Market 

5.1. COVID-19 Landscape: Point-of-Care Testing (POCT) Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Point-of-Care Testing (POCT) Market, By Product Type

8.1. Point-of-Care Testing (POCT) Market, by Product Type, 2024-2034

8.1.1. Covid -19 testing kits

8.1.1.1. Market Revenue and Forecast (2021-2034)

8.1.2. Glucose monitoring products

8.1.2.1. Market Revenue and Forecast (2021-2034)

8.1.3. Cardiometabolic Monitoring Products

8.1.3.1. Market Revenue and Forecast (2021-2034)

8.1.4. Infectious disease testing products

8.1.4.1. Market Revenue and Forecast (2021-2034)

8.1.5. Coagulation monitoring products

8.1.5.1. Market Revenue and Forecast (2021-2034)

8.1.6. Pregnancy and fertility testing products

8.1.6.1. Market Revenue and Forecast (2021-2034)

8.1.7. Pregnancy testing products

8.1.7.1. Market Revenue and Forecast (2021-2034)

8.1.8. Fertility testing products

8.1.8.1. Market Revenue and Forecast (2021-2034)

8.1.9. Cancer marker testing products

8.1.9.1. Market Revenue and Forecast (2021-2034)

8.1.10. Urinanalysis testing products

8.1.10.1. Market Revenue and Forecast (2021-2034)

8.1.11. Cholestrol testing products

8.1.11.1. Market Revenue and Forecast (2021-2034)

8.1.12. Hematology testing products

8.1.12.1. Market Revenue and Forecast (2021-2034)

8.1.13. Drugs-of-abuse testing products

8.1.13.1. Market Revenue and Forecast (2021-2034)

8.1.14. Fecal Occult testing products

8.1.14.1. Market Revenue and Forecast (2021-2034)

8.1.15. Others

8.1.15.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global Point-of-Care Testing (POCT) Market, By Platform

9.1. Point-of-Care Testing (POCT) Market, by Platform, 2024-2034

9.1.1. Lateral Flow Assays

9.1.1.1. Market Revenue and Forecast (2021-2034)

9.1.2. Dipsticks

9.1.2.1. Market Revenue and Forecast (2021-2034)

9.1.3. Microfluids

9.1.3.1. Market Revenue and Forecast (2021-2034)

9.1.4. Molecular Diagnostics

9.1.4.1. Market Revenue and Forecast (2021-2034)

9.1.5. Immunoassays

9.1.5.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global Point-of-Care Testing (POCT) Market, By Mode of Purchase 

10.1. Point-of-Care Testing (POCT) Market, by Mode of Purchase, 2024-2034

10.1.1. OTC products

10.1.1.1. Market Revenue and Forecast (2021-2034)

10.1.2. Prescribed based products

10.1.2.1. Market Revenue and Forecast (2021-2034)

Chapter 11. Global Point-of-Care Testing (POCT) Market, By Testing Type

11.1. Point-of-Care Testing (POCT) Market, by Testing Type, 2024-2034

11.1.1. Immunoassays

11.1.1.1. Market Revenue and Forecast (2021-2034)

11.1.2. Cell-Based Assays

11.1.2.1. Market Revenue and Forecast (2021-2034)

11.1.3. Nucleic Acid Amplification Testing

11.1.3.1. Market Revenue and Forecast (2021-2034)

11.1.4. Clinical Chemistry Assays

11.1.4.1. Market Revenue and Forecast (2021-2034)

11.1.5. Hematology

11.1.5.1. Market Revenue and Forecast (2021-2034)

Chapter 12. Global Point-of-Care Testing (POCT) Market, By End-User

12.1. Point-of-Care Testing (POCT) Market, by End-User, 2024-2034

12.1.1. Clinical laboratories

12.1.1.1. Market Revenue and Forecast (2021-2034)

12.1.2. Ambulatory care facilities and physician offices

12.1.2.1. Market Revenue and Forecast (2021-2034)

12.1.3. Pharmacies, retail clinics & E-comm platforms

12.1.3.1. Market Revenue and Forecast (2021-2034)

12.1.4. Hospitals, Critical care centres, Urgent care centres

12.1.4.1. Market Revenue and Forecast (2021-2034)

12.1.5. Home care & self-testing

12.1.5.1. Market Revenue and Forecast (2021-2034)

Chapter 13. Global Point-of-Care Testing (POCT) Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Product Type (2021-2034)

13.1.2. Market Revenue and Forecast, by Platform (2021-2034)

13.1.3. Market Revenue and Forecast, by Mode of Purchase (2021-2034)

13.1.4. Market Revenue and Forecast, by Testing Type (2021-2034)

13.1.5. Market Revenue and Forecast, by End-User (2021-2034)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Product Type (2021-2034)

13.1.6.2. Market Revenue and Forecast, by Platform (2021-2034)

13.1.6.3. Market Revenue and Forecast, by Mode of Purchase (2021-2034)

13.1.6.4. Market Revenue and Forecast, by Testing Type (2021-2034)

13.1.6.5. Market Revenue and Forecast, by End-User (2021-2034) 

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Product Type (2021-2034)

13.1.7.2. Market Revenue and Forecast, by Platform (2021-2034)

13.1.7.3. Market Revenue and Forecast, by Mode of Purchase (2021-2034)

13.1.7.4. Market Revenue and Forecast, by Testing Type (2021-2034)

13.1.7.5. Market Revenue and Forecast, by End-User (2021-2034)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Product Type (2021-2034)

13.2.2. Market Revenue and Forecast, by Platform (2021-2034)

13.2.3. Market Revenue and Forecast, by Mode of Purchase (2021-2034)

13.2.4. Market Revenue and Forecast, by Testing Type (2021-2034) 

13.2.5. Market Revenue and Forecast, by End-User (2021-2034) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Product Type (2021-2034)

13.2.6.2. Market Revenue and Forecast, by Platform (2021-2034)

13.2.6.3. Market Revenue and Forecast, by Mode of Purchase (2021-2034)

13.2.7. Market Revenue and Forecast, by Testing Type (2021-2034) 

13.2.8. Market Revenue and Forecast, by End-User (2021-2034) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Product Type (2021-2034)

13.2.9.2. Market Revenue and Forecast, by Platform (2021-2034)

13.2.9.3. Market Revenue and Forecast, by Mode of Purchase (2021-2034)

13.2.10. Market Revenue and Forecast, by Testing Type (2021-2034)

13.2.11. Market Revenue and Forecast, by End-User (2021-2034)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Product Type (2021-2034)

13.2.12.2. Market Revenue and Forecast, by Platform (2021-2034)

13.2.12.3. Market Revenue and Forecast, by Mode of Purchase (2021-2034)

13.2.12.4. Market Revenue and Forecast, by Testing Type (2021-2034)

13.2.13. Market Revenue and Forecast, by End-User (2021-2034)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Product Type (2021-2034)

13.2.14.2. Market Revenue and Forecast, by Platform (2021-2034)

13.2.14.3. Market Revenue and Forecast, by Mode of Purchase (2021-2034)

13.2.14.4. Market Revenue and Forecast, by Testing Type (2021-2034)

13.2.15. Market Revenue and Forecast, by End-User (2021-2034)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Product Type (2021-2034)

13.3.2. Market Revenue and Forecast, by Platform (2021-2034)

13.3.3. Market Revenue and Forecast, by Mode of Purchase (2021-2034)

13.3.4. Market Revenue and Forecast, by Testing Type (2021-2034)

13.3.5. Market Revenue and Forecast, by End-User (2021-2034)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Product Type (2021-2034)

13.3.6.2. Market Revenue and Forecast, by Platform (2021-2034)

13.3.6.3. Market Revenue and Forecast, by Mode of Purchase (2021-2034)

13.3.6.4. Market Revenue and Forecast, by Testing Type (2021-2034)

13.3.7. Market Revenue and Forecast, by End-User (2021-2034)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Product Type (2021-2034)

13.3.8.2. Market Revenue and Forecast, by Platform (2021-2034)

13.3.8.3. Market Revenue and Forecast, by Mode of Purchase (2021-2034)

13.3.8.4. Market Revenue and Forecast, by Testing Type (2021-2034)

13.3.9. Market Revenue and Forecast, by End-User (2021-2034)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Product Type (2021-2034)

13.3.10.2. Market Revenue and Forecast, by Platform (2021-2034)

13.3.10.3. Market Revenue and Forecast, by Mode of Purchase (2021-2034)

13.3.10.4. Market Revenue and Forecast, by Testing Type (2021-2034)

13.3.10.5. Market Revenue and Forecast, by End-User (2021-2034)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Product Type (2021-2034)

13.3.11.2. Market Revenue and Forecast, by Platform (2021-2034)

13.3.11.3. Market Revenue and Forecast, by Mode of Purchase (2021-2034)

13.3.11.4. Market Revenue and Forecast, by Testing Type (2021-2034)

13.3.11.5. Market Revenue and Forecast, by End-User (2021-2034)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Product Type (2021-2034)

13.4.2. Market Revenue and Forecast, by Platform (2021-2034)

13.4.3. Market Revenue and Forecast, by Mode of Purchase (2021-2034)

13.4.4. Market Revenue and Forecast, by Testing Type (2021-2034)

13.4.5. Market Revenue and Forecast, by End-User (2021-2034)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Product Type (2021-2034)

13.4.6.2. Market Revenue and Forecast, by Platform (2021-2034)

13.4.6.3. Market Revenue and Forecast, by Mode of Purchase (2021-2034)

13.4.6.4. Market Revenue and Forecast, by Testing Type (2021-2034)

13.4.7. Market Revenue and Forecast, by End-User (2021-2034)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Product Type (2021-2034)

13.4.8.2. Market Revenue and Forecast, by Platform (2021-2034)

13.4.8.3. Market Revenue and Forecast, by Mode of Purchase (2021-2034)

13.4.8.4. Market Revenue and Forecast, by Testing Type (2021-2034)

13.4.9. Market Revenue and Forecast, by End-User (2021-2034)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Product Type (2021-2034)

13.4.10.2. Market Revenue and Forecast, by Platform (2021-2034)

13.4.10.3. Market Revenue and Forecast, by Mode of Purchase (2021-2034)

13.4.10.4. Market Revenue and Forecast, by Testing Type (2021-2034)

13.4.10.5. Market Revenue and Forecast, by End-User (2021-2034)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Product Type (2021-2034)

13.4.11.2. Market Revenue and Forecast, by Platform (2021-2034)

13.4.11.3. Market Revenue and Forecast, by Mode of Purchase (2021-2034)

13.4.11.4. Market Revenue and Forecast, by Testing Type (2021-2034)

13.4.11.5. Market Revenue and Forecast, by End-User (2021-2034)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Product Type (2021-2034)

13.5.2. Market Revenue and Forecast, by Platform (2021-2034)

13.5.3. Market Revenue and Forecast, by Mode of Purchase (2021-2034)

13.5.4. Market Revenue and Forecast, by Testing Type (2021-2034)

13.5.5. Market Revenue and Forecast, by End-User (2021-2034)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Product Type (2021-2034)

13.5.6.2. Market Revenue and Forecast, by Platform (2021-2034)

13.5.6.3. Market Revenue and Forecast, by Mode of Purchase (2021-2034)

13.5.6.4. Market Revenue and Forecast, by Testing Type (2021-2034)

13.5.7. Market Revenue and Forecast, by End-User (2021-2034)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Product Type (2021-2034)

13.5.8.2. Market Revenue and Forecast, by Platform (2021-2034)

13.5.8.3. Market Revenue and Forecast, by Mode of Purchase (2021-2034)

13.5.8.4. Market Revenue and Forecast, by Testing Type (2021-2034)

13.5.8.5. Market Revenue and Forecast, by End-User (2021-2034)

Chapter 14. Company Profiles

14.1. Abbott Laboratories

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Roche Diagnostics

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Siemens Healthineers

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Johnson & Johnson

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Danaher Corporation

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Becton, Dickinson and Company (BD)

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Philips Healthcare

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Sysmex Corporation

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Quidel Corporation

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Chembio Diagnostics

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global point-of-care testing (POCT) market size was accounted at USD 39.64 billion in 2024 and it is expected to reach around USD 125.33 billion by 2034.

The global point-of-care testing (POCT) market is poised to grow at a CAGR of 12.20% from 2024 to 2034.

The major players operating in the point-of-care testing (POCT) market are Sinocare Inc, Hoffmann La Roche Ltd, Siemens AG, Abott Laboratories, bioMrieux SA, Becton Dickinson and Company, Danaher Coraporation, Nova Biomedical, Sysmex corporation, Johnson and Johnson, Biosensor Inc, Fluxergy, Precision, Ascensia Diabetes Care Holding AG, LifeScan IP Holdings, LLC, Mankind pharma, OraSure Technologies, inc, A. Menarini Diagnostics s.r.l, ACON Laboratories, Trinity Biotech plc

Increasing prevalence of chronic disorders, increased R&D with new innovative techniques and developing infrastructure & healthcare facilities these are driving the growth of the point-of-care testing (POCT) market.

North America region will lead the global point-of-care testing (POCT) market during the forecast period 2024 to 2034.

Proceed To Buy

USD 4900
USD 3800
USD 2100
USD 2100
USD 7500
Immediate Delivery Available

Plan your call and get expert insights!

Schedule a Meeting Schedule a Meeting

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

down-arrow-imgGet a Sample

Connect with us now; your solution awaits on the other side!

Contact Us